Skip to main content
Top
Published in: Internal and Emergency Medicine 5/2017

01-08-2017 | IM - CASE RECORD

A unique pneumopathy in a patient with skin nodules and abscesses

Authors: Giovanni Damiani, Nicola di Meo, Angelo Valerio Marzano

Published in: Internal and Emergency Medicine | Issue 5/2017

Login to get access

Excerpt

A 34-year-old man was referred to the Department of Dermatology of our hospital because of a presumed diagnosis of perianal Crohn’s disease. Medical history was positive for severe acne, while there was no positive family history for either inflammatory bowel diseases or allergies. On physical examination, the patient was apyretic, with a blood pressure of 132/86 mmHg, heart rate of 76 beats/min, 17 breaths/min, 97% oxygen saturation in room air. He reported a mild dyspnea occurred 1 month before, with Valleix points examination negative; however, auscultation revealed some crackles prevalently in the bases. Dermatological assessment showed multiple deep-seated inflamed nodules, fistulas and bridging scars on armpits and perianal area with scrotal involvement (Fig. 1). Laboratory investigations demonstrated an increased erythrocyte sedimentation rate (76 mm/h; range 20–50 mm/h); C-reactive protein was also elevated (18 mg/L; range 0.2–5 mg/L). Urine examination, procalcitonine and quantiferon-tests were negative. Therapy was initially azithromycin 500 mg daily for 3 consecutive days weekly for 6 weeks. At the same time, the dyspnea was also evaluated.
Literature
2.
go back to reference Damiani G, Della Valle V, Iannone M et al (2016) Autoinflammatory disease damage index (ADDI): a possible newborn also in hidradenitis suppurativa daily practice. Ann Rheum Dis. doi:10.1136/annrheumdis-2016-210901 (Epub ahead of print) PubMed Damiani G, Della Valle V, Iannone M et al (2016) Autoinflammatory disease damage index (ADDI): a possible newborn also in hidradenitis suppurativa daily practice. Ann Rheum Dis. doi:10.​1136/​annrheumdis-2016-210901 (Epub ahead of print) PubMed
4.
go back to reference van der Zee HH, de Ruiter L, van den Broecke DG et al (2011) Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β. Br J Dermatol 164:1292–1298CrossRefPubMed van der Zee HH, de Ruiter L, van den Broecke DG et al (2011) Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β. Br J Dermatol 164:1292–1298CrossRefPubMed
6.
go back to reference de Jesus AA, Canna SW, Liu Y, Goldbach-Mansky R (2015) Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling. Annu Rev Immunol 33:823–874CrossRefPubMedPubMedCentral de Jesus AA, Canna SW, Liu Y, Goldbach-Mansky R (2015) Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling. Annu Rev Immunol 33:823–874CrossRefPubMedPubMedCentral
7.
go back to reference Marzano AV, Menicanti C, Crosti C, Trevisan V (2013) Neutrophilic dermatoses and inflammatory bowel diseases. G Ital Dermatol Venereol 148:185–196PubMed Marzano AV, Menicanti C, Crosti C, Trevisan V (2013) Neutrophilic dermatoses and inflammatory bowel diseases. G Ital Dermatol Venereol 148:185–196PubMed
8.
go back to reference Marzano AV, Damiani G (2016) Neutrophilic panniculitis and autoinflammation: what’s the link? Br J Dermatol 175:646–647CrossRefPubMed Marzano AV, Damiani G (2016) Neutrophilic panniculitis and autoinflammation: what’s the link? Br J Dermatol 175:646–647CrossRefPubMed
9.
go back to reference Wallach D, Vignon-Pennamen MD (2006) From acute febrile neutrophilic dermatosis to neutrophilic disease: forty years of clinical research. J Am Acad Dermatol 55:1066–1067CrossRefPubMed Wallach D, Vignon-Pennamen MD (2006) From acute febrile neutrophilic dermatosis to neutrophilic disease: forty years of clinical research. J Am Acad Dermatol 55:1066–1067CrossRefPubMed
10.
go back to reference Damiani G, Radaeli A, Olivini A et al (2016) Increased airway inflammation in patients with psoriasis. Br J Dermatol 175:797–799CrossRefPubMed Damiani G, Radaeli A, Olivini A et al (2016) Increased airway inflammation in patients with psoriasis. Br J Dermatol 175:797–799CrossRefPubMed
11.
go back to reference Malerba M, Damiani G, Radaeli A et al (2015) Narrow-band ultraviolet b phototherapy in psoriasis reduces pro-inflammatory cytokine levels and improves vitiligo and neutrophilic asthma. Br J Dermatol 173:1544–1546CrossRefPubMed Malerba M, Damiani G, Radaeli A et al (2015) Narrow-band ultraviolet b phototherapy in psoriasis reduces pro-inflammatory cytokine levels and improves vitiligo and neutrophilic asthma. Br J Dermatol 173:1544–1546CrossRefPubMed
12.
go back to reference Kimball AB, Okun MM, Williams DA et al (2016) Two phase 3 trials of adalimumab for hidradenitis suppurativa. N Engl J Med 4(375):422–434CrossRef Kimball AB, Okun MM, Williams DA et al (2016) Two phase 3 trials of adalimumab for hidradenitis suppurativa. N Engl J Med 4(375):422–434CrossRef
13.
go back to reference Megna M, Bettoli V, Chimenti S et al (2015) Hidradenitis suppurativa: guidelines of the Italian Society of Dermatology and Venereology (SIDeMaST) for the use of anti-TNF-α agents. G Ital Dermatol Venereol 150:731–739PubMed Megna M, Bettoli V, Chimenti S et al (2015) Hidradenitis suppurativa: guidelines of the Italian Society of Dermatology and Venereology (SIDeMaST) for the use of anti-TNF-α agents. G Ital Dermatol Venereol 150:731–739PubMed
14.
go back to reference Marzano AV, Ceccherini I, Gattorno M et al (2014) Association of pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) shares genetic and cytokine profiles with other autoinflammatory diseases. Medicine (Baltimore) 93:e187CrossRef Marzano AV, Ceccherini I, Gattorno M et al (2014) Association of pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) shares genetic and cytokine profiles with other autoinflammatory diseases. Medicine (Baltimore) 93:e187CrossRef
15.
go back to reference Miller IM, McAndrew RJ, Hamzavi I (2016) Prevalence, risk factors, and comorbidities of hidradenitis suppurativa. Dermatol Clin 34:7–16CrossRefPubMed Miller IM, McAndrew RJ, Hamzavi I (2016) Prevalence, risk factors, and comorbidities of hidradenitis suppurativa. Dermatol Clin 34:7–16CrossRefPubMed
16.
go back to reference Lima AL, Karl I, Giner T et al (2016) Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa. Br J Dermatol 174:514–521CrossRefPubMed Lima AL, Karl I, Giner T et al (2016) Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa. Br J Dermatol 174:514–521CrossRefPubMed
17.
go back to reference Marzano AV (2016) Hidradenitis suppurativa, neutrophilic dermatoses and autoinflammation: what’s the link? Br J Dermatol 174:482–483CrossRefPubMed Marzano AV (2016) Hidradenitis suppurativa, neutrophilic dermatoses and autoinflammation: what’s the link? Br J Dermatol 174:482–483CrossRefPubMed
18.
go back to reference Marzano AV, Borghi A, Meroni PL, Cugno M (2016) Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation. Br J Dermatol. doi:10.1111/bjd.14691 (review) Marzano AV, Borghi A, Meroni PL, Cugno M (2016) Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation. Br J Dermatol. doi:10.​1111/​bjd.​14691 (review)
Metadata
Title
A unique pneumopathy in a patient with skin nodules and abscesses
Authors
Giovanni Damiani
Nicola di Meo
Angelo Valerio Marzano
Publication date
01-08-2017
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 5/2017
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-017-1658-0

Other articles of this Issue 5/2017

Internal and Emergency Medicine 5/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.